Engineered Plant-Derived Extracellular Vesicles as Targeted Drug Carriers in Cancer Therapy
ACS Applied Bio Materials · 19.01.2026 · 9 (2) · 1053-1063
DOI: 10.1021/acsabm.5c01943 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 17.12.2025. Verfasst von Su Jin Kang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering and Nano-Bioengineering, Incheon National University, Incheon 22012, Republic of Korea. Hauptthemen laut MEDLINE: Extracellular Vesicles, Drug Carriers, Doxorubicin, Glycine max. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: National Research Foundation of Korea, Korea Polar Research Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering and Nano-Bioengineering, Incheon National University, Incheon 22012, Republic of Korea.
- Research Center for Bio Materials & Process Development, Incheon National University, Incheon 22012, Republic of Korea.
- Division of Bioengineering, Incheon National University, Incheon 22012, Republic of Korea.
ORCID-Profile: Su Jin Kang, Won Jong Rhee
Förderung
- National Research Foundation of Korea
- Korea Polar Research Institute
Zitieren
APA
Kang, S. J., & Rhee, W. J. (2026). Engineered Plant-Derived Extracellular Vesicles as Targeted Drug Carriers in Cancer Therapy. ACS Applied Bio Materials, 9(2), 1053-1063. https://doi.org/10.1021/acsabm.5c01943
Vancouver
Kang SJ, Rhee WJ. Engineered Plant-Derived Extracellular Vesicles as Targeted Drug Carriers in Cancer Therapy. ACS Applied Bio Materials. 2026;9(2):1053-1063. doi:10.1021/acsabm.5c01943
BibTeX
@article{Kang2026,
author = {Kang, Su Jin and Rhee, Won Jong},
title = {Engineered Plant-Derived Extracellular Vesicles as Targeted Drug Carriers in Cancer Therapy},
journal = {ACS Applied Bio Materials},
year = {2026},
volume = {9},
number = {2},
pages = {1053--1063},
doi = {10.1021/acsabm.5c01943}
}
EUVIMED